Breaking Finance News

Danone SA (ADR) (NASDAQ:DANOY) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.

Displaying a price of $14.30, Danone SA (ADR) (NASDAQ:DANOY) traded 1.13% lower on the day. The last stock price close is down 0.44% from the 200-day moving average, compared to the S&P 500 which has fallen -0.01% over the date range. Danone SA (ADR) has been tracking to a 50-day moving average of $15.29 and two hundred day moving average of $14.36. 289,819 shares of DANOY traded hands, down from ann avg. volume of 1,171,520

Zacks Investment Research has downgraded Danone SA (ADR)(NASDAQ:DANOY) to Hold in a statement released 9/16/2016.

On Tuesday September 13 2016, Zacks Investment Research reported on Danone SA (ADR)(NASDAQ:DANOY) upped the target price from $0.00 to $16.00 that suggested an upside of 0.10%.

See Graph Below:

Danone SA (ADR) (NASDAQ:DANOY)

Danone SA (ADR) has a P/E of 23 with a 52 week low of $12.10 and a one-year high of $15.77. Danone SA (ADR)’s market cap is currently $0.0.

Brief Synopsis About Danone SA (ADR) (NASDAQ:DANOY)

Danone SA is engaged in holding directly or indirectly companies, and coordination of the main functions and activities. The Company operates through four segments: Fresh Dairy Products Division, Waters Division, Early Life Nutrition Division and Medical Nutrition Division. The Fresh Dairy Products Division is engaged in the production and distribution of yogurts, fermented dairy products and other fresh dairy specialties. The Waters Division is engaged in the production and distribution of packaged natural, and flavored and vitamin-enriched water. The Early Life Nutrition Division is engaged in the production and distribution of specialized food for babies and young children to complement breast-feeding. The Medical Nutrition Division is engaged in the production and distribution of specialized food for people afflicted with certain illnesses or frail elderly people.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.